Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Winer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Archives of Internal Medicine|December 10, 2003
Role of the natriuretic peptide system in cardiorenal protectionSamy I McFarlane, Nathaniel Winer, James R Sowers
Current Diabetes Reports|July 16, 2008
Vascular compliance in hypertension: therapeutic implicationsHo Won Lee, Jocelyn Karam, Babar Hussain, et al.
Metabolism: Clinical and Experimental|September 13, 2005
High-fat meal impairs vascular compliance in a subgroup of young healthy subjectsMihaela C Blendea, Mara Bard, James R Sowers, et al.
Cardiorenal Medicine|March 5, 2015
Vascular compliance in lean, obese, and diabetic children and adolescents: a cross-sectional study in a minority populationDeep Shikha, Montish Singla, Rachna Walia, et al.
Cardiorenal Medicine|July 22, 2015
Ambulatory Blood Pressure Monitoring in Lean, Obese and Diabetic Children and AdolescentsDeep Shikha, Montish Singla, Rachna Walia, et al.
Journal of the Cardiometabolic Syndrome|August 9, 2007
Vascular compliance in women with polycystic ovary syndrome and healthy womenOzgul Muneyyirci-Delale, Nathaniel Winer, Vita Oklander, et al.
Preventive Cardiology|April 30, 2005
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetesNathaniel Winer, Amy Folker, Julie A Murphy, et al.
Diabetes Care|March 29, 2002
Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centersSamy I McFarlane, Scott J Jacober, Nathaniel Winer, et al.
Archives of Internal Medicine|January 26, 2005
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitusJames R Sowers, William B White, Bertram Pitt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 9, 2010
Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 ratVincent G DeMarco, Megan S Johnson, Javad Habibi, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Archives of Internal Medicine|December 10, 2003
Role of the natriuretic peptide system in cardiorenal protectionSamy I McFarlane, Nathaniel Winer, James R Sowers
Current Diabetes Reports|July 16, 2008
Vascular compliance in hypertension: therapeutic implicationsHo Won Lee, Jocelyn Karam, Babar Hussain, et al.
Metabolism: Clinical and Experimental|September 13, 2005
High-fat meal impairs vascular compliance in a subgroup of young healthy subjectsMihaela C Blendea, Mara Bard, James R Sowers, et al.
Cardiorenal Medicine|March 5, 2015
Vascular compliance in lean, obese, and diabetic children and adolescents: a cross-sectional study in a minority populationDeep Shikha, Montish Singla, Rachna Walia, et al.
Cardiorenal Medicine|July 22, 2015
Ambulatory Blood Pressure Monitoring in Lean, Obese and Diabetic Children and AdolescentsDeep Shikha, Montish Singla, Rachna Walia, et al.
Journal of the Cardiometabolic Syndrome|August 9, 2007
Vascular compliance in women with polycystic ovary syndrome and healthy womenOzgul Muneyyirci-Delale, Nathaniel Winer, Vita Oklander, et al.
Preventive Cardiology|April 30, 2005
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetesNathaniel Winer, Amy Folker, Julie A Murphy, et al.
Diabetes Care|March 29, 2002
Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centersSamy I McFarlane, Scott J Jacober, Nathaniel Winer, et al.
Archives of Internal Medicine|January 26, 2005
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitusJames R Sowers, William B White, Bertram Pitt, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 9, 2010
Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 ratVincent G DeMarco, Megan S Johnson, Javad Habibi, et al.
Pageof 2